Latest News and Press Releases

Fabhalta lowered likelihood of progression to kidney failure by 43% in APPLAUSE-IgAN study140.7% of patients on Fabhalta demonstrated sustained reduction of protein in urine over two years1Fabhalta...

Dubai, UAE, March 28, 2026 (GLOBE NEWSWIRE) -- Pepeto presale crossed $8.47 million after its latest presale round closed ahead of schedule, and the crypto news connecting this project to the BNB...

Dubai, UAE, March 28, 2026 (GLOBE NEWSWIRE) -- Pepeto pushed past $8.47 million after its latest round closed ahead of schedule while the crypto news today delivered the catalysts this bull run has...

Dubai, UAE, March 28, 2026 (GLOBE NEWSWIRE) -- The Pepeto team confirmed a major update to the exchange infrastructure as the presale pushes past $8.47 million with entries arriving faster every...

Gelatin trick 2026 warning: does the viral gelatin trick recipe work? Pink gelatin trick, ice gelatin trick, and Gelatine Sculpt examined.

2026 SteelPower performance report covers male enhancement formula details, ingredient research context, pricing, and guarantee disclosures.

Results from the Phase 3 VELA clinical trials in adults with moderate-to-severe hidradenitis suppurativa (HS) show that clinical responses continue to improve to Week 40, with 62% of patients treated...

The results of the Phase 3 VALOR trial were published in the New England Journal of Medicine, underscoring the practice-changing potential of brepocitinib 30 mg once-daily in...

In the Phase 2 part of the AMETHYST study, litifilimab met the primary endpoint of reduction of disease activity in people living with CLE at Week 16, with more litifilimab participants achieving...

Gelatide Drops under investigation: 2026 consumer report on Gelatide-1 claims, fake gelatin trick recipe, ingredient research, and refund terms.